Saturday 1 November 2014
 
»
Tag
 
»
clinical trial

Linagliptin 'significantly lowers blood glucose'

Phase III studies of Linagliptin, a compound being investigated by Boehringer Ingelheim as a once-daily oral treatment in type 2 diabetes, showed that the drug significantly lowered blood glucose, a report said. The drug, a dipeptidyl pept

Moreā€¦
 1 2 3 4 5 >  Last ›

calendarCalendar of Events

Ads